Sanara MedTechSMTI +2.98%72 Market Cap is $218.8 Mil as of Jun. 28, 2026. GuruFocus rates SMTI with a GF Score™ of 72/100 and a GF Value™ of $45.54 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Sanara MedTech ranks better than 57.6% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sanara MedTech's share price for the quarter that ended in Mar. 2026 was $17.18. Sanara MedTech's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 9.2 Mil. Therefore, Sanara MedTech's market cap for the quarter that ended in Mar. 2026 was $157.5 Mil.
Sanara MedTech's quarterly market cap
declined
from Sep. 2025 ($283.4 Mil) to Dec. 2025 ($208.9 Mil) and
declined
from Dec. 2025 ($208.9 Mil) to Mar. 2026 ($157.5 Mil).
Sanara MedTech's annual market cap
declined
from Dec. 2023 ($350.8 Mil) to Dec. 2024 ($290.6 Mil) and
declined
from Dec. 2024 ($290.6 Mil) to Dec. 2025 ($208.9 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sanara MedTech's Enterprise Value for Today is $253.6 Mil.
Sanara MedTech (NAS:SMTI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sanara MedTech Market Cap Related Terms
Sanara MedTech Market Cap Historical Data
* Premium members only.
The historical data trend for Sanara MedTech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Sanara MedTech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanara MedTech Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sanara MedTech's Market Cap distribution charts can be found below:
* The bar in red indicates where Sanara MedTech's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sanara MedTech's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanara MedTech (SMTI) has a Market Cap of $218.8 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sanara MedTech and its competitors. According to the industry distribution chart, Sanara MedTech ranks #368 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 42.4%.
Is Sanara MedTech's Market Cap too high?
Sanara MedTech's current Market Cap is $218.8 Mil. The Medical Devices & Instruments industry median Market Cap is 118.39. Sanara MedTech's value of $218.8 Mil is 84.8% above this industry median. Based on the distribution chart, Sanara MedTech ranks #368 out of 868 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sanara MedTech has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sanara MedTech's Market Cap compare to PDEX and UTMD?
According to the Medical Devices & Instruments industry distribution chart, Sanara MedTech ranks #368 out of 868 companies for Market Cap. This puts Sanara MedTech in the upper half of its industry. The industry median Market Cap is 118.39. Sanara MedTech's value of $218.8 Mil is 84.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 118.39, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanara MedTech's current Market Cap of $218.8 Mil is 84.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sanara MedTech and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 118.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanara MedTech's current Market Cap is $218.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanara MedTech stock overvalued right now?
Based on GuruFocus' analysis, Sanara MedTech (SMTI) is currently considered Possible Value Trap. The stock's GF Value™ is $45.54, compared to a current price of $23.88 — trading 47.6% below its estimated fair value. The current Market Cap is $218.8 Mil and 84.8% above the Medical Devices & Instruments industry median of 118.39. Sanara MedTech's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sanara MedTech (SMTI), the current Market Cap is $218.8 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sanara MedTech (SMTI) Overvalued in 2026?
Based on GuruFocus' analysis, Sanara MedTech stock appears to be undervalued.
The current stock price of $23.88 is trading 47.6% below its estimated GF Value™ of $45.54.
GuruFocus considers Sanara MedTech to be Possible Value Trap.
Key valuation signals for SMTI:
Market Cap: $218.8 Mil
GF Value™: $45.54 vs. price of $23.88 (47.6% below fair value)
Industry Position: 84.8% above the Medical Devices & Instruments median (#368 of 868)
No single metric tells the full story. See the SMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
72GF Score
Get the complete analysis for SMTI
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SMTI has been successfully added to your 
